[ Sino Biological raises $29.41M in Series A ]

Sino Biological has raised $29.41 million in Series A funding.

Founded in 2007, Sino Biological  is engaged in the research and development of recombinant protein and antibody reagents for the treatment of cancer and arthritis.

The products can be used to treat a number of diseases such as lung cancer, colorectal cancer, lymphoma, arthritis and Hemophilia.

Funding  Series  A
Founded  2007
Country  China
City  Beijing, Beijing Municipality
Founder / CEO  Liangzhi Xie
Deal Size  $29.41M
Investors  Qiming Venture Partners
Previous Investors  /